Purchase Order 75N95023P00573
Award Date 8/21/23
Potential Completion Date 12/22/23
Potential Value $25K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Spain
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Center for Advancing Translational Sciences, to Enzymlogic SL, a for-profit, woman-owned business located in Spain. The contract is for the evaluation of selected agents in time-resolved fluorescence energy transfer (TR-FRET) assays for selected kinase targets, with a firm fixed price of $129,720.00 and a completion date of March 15, 2023. The contract does...
- This $19,833.68 firm fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Reaction Biology Corporation, a self-certified small disadvantaged business. The contract is for profiling 10 BTK (Bruton's tyrosine kinase) inhibitors against a panel of 20 kinases. Reaction Biology is a drug discovery contract research organization that specializes in enzyme...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,472 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide protein analysis services and equipment. The place of performance is in Potomac, Maryland through October 13, 2023. As part of NIH's efforts to advance translational sciences and support, this award will enable Proteinsimple to...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $110,000.00 firm fixed price purchase order to Reaction Biology Corporation, a self-certified small disadvantaged business, for the testing of compounds to inhibit wild-type kinase enzymes. This requirement does not have a set-aside designation. Reaction Biology Corporation is a contract research organization that provides specialized bioassay testing and...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $11,340 firm fixed-price purchase order to BPS Bioscience Inc. for a biochemical IC50 screening study. The contract calls for the vendor to conduct inhibitory concentration testing on twelve compounds plus one control against three protein kinase targets: PKM2, PKL, and PKR. This procurement supports NCATS's mission to accelerate the translation of laboratory discoveries into clinical applications by providing critical...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of Acquisitions awarded a $103,508.51 purchase order to Trenzyme GmbH of Bethesda, Maryland. The contract calls for the prime contractor to perform PCR-amplification and cloning of a tet-on inducible exoin-C/E3/E2/6K/E1 vector to support the agency's biomedical research efforts. Work will be conducted in Bethesda through January 18, 2010 under a fixed price...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Eurofins Discoverx Products, LLC, a foreign-owned, self-certified small disadvantaged business, for a PathHunter Detection Kit. The potential value of the contract is $30,778.40, with a completion date of August 25, 2021. The services provided under this contract appear to be in support of the agency's mission of advancing...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Activx Biosciences, Inc., a foreign-owned for-profit organization. The $180,600 contract is for kinase profiling services, with a completion date of November 29, 2022. Activx Biosciences has previously provided similar drug discovery and profiling services to other NIH entities such as the National Cancer Institute...
- This $29,376 firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Reaction Biology Corporation, a self-certified small disadvantaged business. The award is to obtain kinase hotspot assay compound testing services from Reaction Biology. This contract is not associated with a larger vehicle. The purpose is to test 120 novel small molecule compounds for inhibitory activity...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey. The order is for photoredox chemistry discovery services with a completion date of November 4, 2022. No set-aside designation was used for this award to support the National Center's programs in translational sciences. The potential value matches the award amount to...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,950 purchase order to Enzymlogic SL of Spain. Under the firm fixed price contract, Enzymlogic will conduct profiling of nine BTK inhibitors versus the active and inactive form of the enzyme from August 21, 2023 through December 22, 2023. The contract supports the National Institutes of Health's efforts to advance biomedical research and development by facilitating translation of scientific discoveries into therapies and diagnostics for patients. No subcontractors or set aside designations were identified in the award information.
Generated 12/18/23, 3:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 8/15/23 |